Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Studies a screening method for familial high cholesterol in people taking part in screening

Looks at people screened for familial high cholesterol and later heart disease outcomes.

Key facts

Who runs it
Karolinska Institutet
Where
Stockholm, SwedenSee the site
Trial code
Registry title
Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia
Status
Enrolling by invitation
People taking part
30,000 people, planned
Started
1 Sept 2021
Expected to end
Sept 2033
Type of study
Observational
Record updated
16 March 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The study includes people taking part in the national screening program for familial hypercholesterolemia. Anyone with a Swedish personal identification number can join.

Sex
Anyone can join, women and men.

Main reasons for not taking part

  • People who decline informed consent cannot join.

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Swedish personal identification number

Who cannot take part

  • Decline informed consent

Where in Sweden

  • Karolinska University HospitalStockholm, SwedenNo longer taking part

About the trial

What the trial wants to find out

Longitudinal and observational registry-based cohort study of individuals participating in the national digiphysical screening program for Familial Hypercholesterolemia. The information collected in the screening process will be combined in pseudo-anonymous form with data from the National Board of Health and Welfare (registries: Cause of Death, Diagnoses according to International Classification of Diseases (ICD) and Prescribed drugs) and Statistic Sweden (Longitudinal integrated database for health insurance and labour market studies). Primary analysis: association between Familial Hypercholesterolemia and cardiovascular disease. Secondary analysis: efficacy and health economic aspects of digiphysical screening for Familial Hypercholesterolemia.

The group in the trial

  • Individuals screened for Familial Hypercholesterolemia

    Individuals participating in diagnostic activities in the digiphysical health care screening program for Familial Hypercholesterolemia and have provided informed consent are included in the cohort.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of Digiphysical Screening for Familial Hypercholesterolemia - Efficacy of Digiphysical Screening, Effects on Cardiovascular Morbidity and Mortality and Health Economic Aspects
Plain-language title
Studies a screening method for familial high cholesterol in people taking part in screeningGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
16 March 2023